vs

Side-by-side financial comparison of Ascendis Pharma A/S (ASND) and GigaCloud Technology Inc (GCT). Click either name above to swap in a different company.

GigaCloud Technology Inc is the larger business by last-quarter revenue ($332.6M vs $267.3M, roughly 1.2× Ascendis Pharma A/S). On growth, Ascendis Pharma A/S posted the faster year-over-year revenue change (42.3% vs 9.7%). Over the past eight quarters, Ascendis Pharma A/S's revenue compounded faster (60.7% CAGR vs 36.6%).

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

GigaCloud Technology Inc. is an American e-commerce company that helps retailers buy and sell big and bulky, non-standardized items such as furniture, appliances, and fitness equipment. They own a business-to-business online marketplace and act as a middleman by handling sales, logistics and also delivery to end customers. GigaCloud is headquartered in El Monte, California, and is listed on the Nasdaq stock exchange since August 2022.

ASND vs GCT — Head-to-Head

Bigger by revenue
GCT
GCT
1.2× larger
GCT
$332.6M
$267.3M
ASND
Growing faster (revenue YoY)
ASND
ASND
+32.6% gap
ASND
42.3%
9.7%
GCT
Faster 2-yr revenue CAGR
ASND
ASND
Annualised
ASND
60.7%
36.6%
GCT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASND
ASND
GCT
GCT
Revenue
$267.3M
$332.6M
Net Profit
$37.2M
Gross Margin
90.5%
23.2%
Operating Margin
12.2%
Net Margin
11.2%
Revenue YoY
42.3%
9.7%
Net Profit YoY
-8.6%
EPS (diluted)
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASND
ASND
GCT
GCT
Q4 25
$267.3M
Q3 25
$230.7M
$332.6M
Q2 25
$170.7M
$322.6M
Q1 25
$109.0M
$271.9M
Q4 24
$187.8M
$295.8M
Q3 24
$62.5M
$303.3M
Q2 24
$38.9M
$310.9M
Q1 24
$103.6M
$251.1M
Net Profit
ASND
ASND
GCT
GCT
Q4 25
Q3 25
$-65.9M
$37.2M
Q2 25
$-42.0M
$34.6M
Q1 25
$-102.2M
$27.1M
Q4 24
$31.0M
Q3 24
$-107.1M
$40.7M
Q2 24
$-118.1M
$27.0M
Q1 24
$-141.5M
$27.2M
Gross Margin
ASND
ASND
GCT
GCT
Q4 25
90.5%
Q3 25
89.5%
23.2%
Q2 25
80.1%
23.9%
Q1 25
82.6%
23.4%
Q4 24
91.9%
22.0%
Q3 24
80.6%
25.5%
Q2 24
68.2%
24.6%
Q1 24
92.1%
26.5%
Operating Margin
ASND
ASND
GCT
GCT
Q4 25
Q3 25
5.1%
12.2%
Q2 25
-33.5%
11.1%
Q1 25
-103.2%
10.4%
Q4 24
9.3%
Q3 24
-167.3%
13.4%
Q2 24
-370.2%
8.8%
Q1 24
-51.2%
13.9%
Net Margin
ASND
ASND
GCT
GCT
Q4 25
Q3 25
-28.5%
11.2%
Q2 25
-24.6%
10.7%
Q1 25
-93.7%
10.0%
Q4 24
10.5%
Q3 24
-171.5%
13.4%
Q2 24
-303.9%
8.7%
Q1 24
-136.6%
10.8%
EPS (diluted)
ASND
ASND
GCT
GCT
Q4 25
Q3 25
$0.99
Q2 25
$0.91
Q1 25
$0.68
Q4 24
$0.76
Q3 24
$0.98
Q2 24
$0.65
Q1 24
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASND
ASND
GCT
GCT
Cash + ST InvestmentsLiquidity on hand
$665.3M
$365.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-175.8M
$457.3M
Total Assets
$1.4B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASND
ASND
GCT
GCT
Q4 25
$665.3M
Q3 25
$582.2M
$365.9M
Q2 25
$533.6M
$303.0M
Q1 25
$559.4M
$286.8M
Q4 24
$604.3M
$302.4M
Q3 24
$675.6M
$259.8M
Q2 24
$279.4M
$207.8M
Q1 24
$345.9M
$195.3M
Stockholders' Equity
ASND
ASND
GCT
GCT
Q4 25
$-175.8M
Q3 25
$-188.0M
$457.3M
Q2 25
$-202.6M
$431.4M
Q1 25
$-205.0M
$412.9M
Q4 24
$-114.2M
$405.2M
Q3 24
$-105.1M
$400.4M
Q2 24
$-346.8M
$358.4M
Q1 24
$-257.2M
$317.8M
Total Assets
ASND
ASND
GCT
GCT
Q4 25
$1.4B
Q3 25
$1.2B
$1.1B
Q2 25
$1.2B
$1.1B
Q1 25
$1.1B
$1.1B
Q4 24
$1.3B
$1.1B
Q3 24
$1.2B
$1.1B
Q2 24
$819.0M
$1.1B
Q1 24
$866.7M
$977.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASND
ASND
GCT
GCT
Operating Cash FlowLast quarter
$58.2M
$78.3M
Free Cash FlowOCF − Capex
$77.1M
FCF MarginFCF / Revenue
23.2%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
2.10×
TTM Free Cash FlowTrailing 4 quarters
$188.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASND
ASND
GCT
GCT
Q4 25
$58.2M
Q3 25
$78.3M
Q2 25
$38.6M
Q1 25
$-15.5M
$9.4M
Q4 24
$-330.7M
$68.4M
Q3 24
$55.2M
Q2 24
$19.1M
Q1 24
$-109.7M
$15.3M
Free Cash Flow
ASND
ASND
GCT
GCT
Q4 25
Q3 25
$77.1M
Q2 25
$37.0M
Q1 25
$7.0M
Q4 24
$66.9M
Q3 24
$51.4M
Q2 24
$12.9M
Q1 24
$11.3M
FCF Margin
ASND
ASND
GCT
GCT
Q4 25
Q3 25
23.2%
Q2 25
11.5%
Q1 25
2.6%
Q4 24
22.6%
Q3 24
16.9%
Q2 24
4.2%
Q1 24
4.5%
Capex Intensity
ASND
ASND
GCT
GCT
Q4 25
Q3 25
0.4%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
0.5%
Q3 24
1.3%
Q2 24
2.0%
Q1 24
1.6%
Cash Conversion
ASND
ASND
GCT
GCT
Q4 25
Q3 25
2.10×
Q2 25
1.12×
Q1 25
0.35×
Q4 24
2.21×
Q3 24
1.36×
Q2 24
0.71×
Q1 24
0.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASND
ASND

Segment breakdown not available.

GCT
GCT

Services$108.4M33%
Transferred Over Time$89.8M27%
Product Sales To B$50.1M15%
Last Mile Delivery Service$49.2M15%
Warehousing Service$14.2M4%
Ocean Transportation Service$9.0M3%
Platform Commission$4.9M1%
Drayage Service$3.2M1%

Related Comparisons